发明名称 Vektor til oral indgivelse
摘要 Vector (A), for oral administration of at least one pharmacologically active substance (I), that allows passage of (I) from the lumen of the intestines into the blood, optionally through interstitial fluid, without significant denaturation or degradation. (A) comprises an essentially hydrophilic matrix the outer surface of which is modified by one or more chemical species (II) that confer lipophilicity to (A). Independent claims are also included for the following: (1) gastric resistant vehicles (B) that comprise one or more (A); and (2) pharmaceutical composition containing at least one (A) or (B). ACTIVITY : Antidiabetic. No biological data given. MECHANISM OF ACTION : Vaccine; insulin substitution.
申请公布号 DK1633392(T3) 申请公布日期 2016.06.27
申请号 DK20040742551T 申请日期 2004.04.20
申请人 Centre Européen dÉtude du Diabète;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 发明人 FRERE, Yves;DANICHER, Louis;BELCOURT, Alain
分类号 A61K38/28;A61K9/16;A61K9/48;A61K9/50;A61K9/51;A61K9/52;A61K38/00;A61P3/10 主分类号 A61K38/28
代理机构 代理人
主权项
地址